Altered manganese homeostasis: Implications for BLI-3-dependent dopaminergic neurodegeneration and SKN-1 protection in C. elegans

Journal of Trace Elements in Medicine and Biology

Volumn 26, Issue 2-3, 2012, Pages 183-187

  Chakraborty, Sudipta ^a,b   Aschner, Michael ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

BLI 3; DMT1 SMF; Manganese; Parkinson's disease; SKN 1 Nrf2

Indexed keywords

DOPAMINE; LEVODOPA; MANGANESE; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; OXIDOREDUCTASE; PROTEIN BLI 3; PROTEIN SKN 1; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CAENORHABDITIS ELEGANS; CELL TRANSPORT; DEGENERATIVE DISEASE; DOPAMINERGIC SYSTEM; DYSKINESIA; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; HOMEOSTASIS; HUMAN; INTOXICATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYMPTOMATOLOGY;

ANIMALS; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; DNA-BINDING PROTEINS; HOMEOSTASIS; MANGANESE; NEURODEGENERATIVE DISEASES; OXIDOREDUCTASES; TRANSCRIPTION FACTORS;

CAENORHABDITIS ELEGANS; PARKINSONIA;

EID: 84862538256     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2012.03.011     Document Type: Article

References (36)

1. ATSDR Toxicological profile for manganese (Draft for Public Comment) 2008, U.S. Department of Health and Human Services, Public Service, Atlanta, GA.
2. Aschner J.L., Aschner M. Nutritional aspects of manganese homeostasis. Mol Aspects Med 2005, 26(4-5):353-362.
3. Dobson A.W., Erikson K.M., Aschner M. Manganese neurotoxicity. Ann N Y Acad Sci 2004, 1012:115-128.
4. Touret N., Furuya W., Forbes J., Gros P., Grinstein S. Dynamic traffic through the recycling compartment couples the metal transporter Nramp2 (DMT1) with the transferrin receptor. J Biol Chem 2003, 278(28):25548-25557.
5. Au C., Benedetto A., Aschner M. Manganese transport in eukaryotes: the role of DMT1. Neurotoxicology 2008, 29(4):569-576.
6. Lockman P.R., Roder K.E., Allen D.D. Inhibition of the rat blood-brain barrier choline transporter by manganese chloride. J Neurochem 2001, 79(3):588-594.
7. Crossgrove J.S., Allen D.D., Bukaveckas B.L., Rhineheimer S.S., Yokel R.A. Manganese distribution across the blood-brain barrier. I. Evidence for carrier-mediated influx of manganese citrate as well as manganese and manganese transferrin. Neurotoxicology 2003, 24(1):3-13.
8. 2+ transport. J Biol Chem 2008, 283(48):33365-33374.
9. Gitler A.D., Chesi A., Geddie M.L., Strathearn K.E., Hamamichi S., Hill K.J., et al. Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat Genet 2009, 41(3):308-315.
10. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997, 388(6641):482-488.
11. Andrews N.C. The iron transporter DMT1. Int J Biochem Cell Biol 1999, 31(10):991-994.
12. Huang E., Ong W.Y., Connor J.R. Distribution of divalent metal transporter-1 in the monkey basal ganglia. Neuroscience 2004, 128(3):487-496.
13. Salazar J., Mena N., Hunot S., Prigent A., Alvarez-Fischer D., Arredondo M., et al. Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease. Proc Natl Acad Sci U S A 2008, 105(47):18578-18583.
14. Sriram K., Lin G.X., Jefferson A.M., Roberts J.R., Chapman R.S., Chen B.T., et al. Dopaminergic neurotoxicity following pulmonary exposure to manganese-containing welding fumes. Arch Toxicol 2010, 84(7):521-540.
15. He Q., Du T., Yu X., Xie A., Song N., Kang Q., et al. DMT1 polymorphism and risk of Parkinson's disease. Neurosci Lett 2011, 501(3):128-131.
16. Leung M.C., Williams P.L., Benedetto A., Au C., Helmcke K.J., Aschner M., et al. Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology. Toxicol Sci 2008, 106(1):5-28.
17. Brenner S. The genetics of Caenorhabditis elegans. Genetics 1974, 77(1):71-94.
18. Sulston J., Dew M., Brenner S. Dopaminergic neurons in the nematode Caenorhabditis elegans. J Comp Neurol 1975, 163(2):215-226.
19. Garrick M.D., Dolan K.G., Horbinski C., Ghio A.J., Higgins D., Porubcin M., et al. DMT1: a mammalian transporter for multiple metals. Biometals 2003, 16(1):41-54.
20. Au C., Benedetto A., Anderson J., Labrousse A., Erikson K., Ewbank J.J., et al. SMF-1, SMF-2 and SMF-3 DMT1 orthologues regulate and are regulated differentially by manganese levels in C. elegans. PLoS One 2009, 4(11):e7792.
21. Benedetto A., Au C., Avila D.S., Milatovic D., Aschner M. Extracellular dopamine potentiates Mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans. PLoS Genet 2010, 6(8).
22. Nass R., Hahn M.K., Jessen T., McDonald P.W., Carvelli L., Blakely R.D. A genetic screen in Caenorhabditis elegans for dopamine neuron insensitivity to 6-hydroxydopamine identifies dopamine transporter mutants impacting transporter biosynthesis and trafficking. J Neurochem 2005, 94(3):774-785.
23. Jomova K., Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology 2011, 283(2-3):65-87.
24. Sistrunk S.C., Ross M.K., Filipov N.M. Direct effects of manganese compounds on dopamine and its metabolite Dopac: an in vitro study. Environ Toxicol Pharmacol 2007, 23(3):286-296.
25. Thein M.C., Winter A.D., Stepek G., McCormack G., Stapleton G., Johnstone I.L., et al. Combined extracellular matrix cross-linking activity of the peroxidase MLT-7 and the dual oxidase BLI-3 is critical for post-embryonic viability in Caenorhabditis elegans. J Biol Chem 2009, 284(26):17549-17563.
26. Wu D.C., Teismann P., Tieu K., Vila M., Jackson-Lewis V., Ischiropoulos H., et al. NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Proc Natl Acad Sci U S A 2003, 100(10):6145-6150.
27. Oliveira R.P., Porter Abate J., Dilks K., Landis J., Ashraf J., Murphy C.T., et al. Condition-adapted stress and longevity gene regulation by Caenorhabditis elegans SKN-1/Nrf. Aging Cell 2009, 8(5):524-541.
28. Choi D.H., Cristovao A.C., Guhathakurta S., Lee J., Joh T.H., Beal M.F., et al. NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease. Antioxid Redox Signal 2012, 16(10):1033-1045.
29. Kumar A., Singh B.K., Ahmad I., Shukla S., Patel D.K., Srivastava G., et al. Involvement of NADPH oxidase and glutathione in zinc-induced dopaminergic neurodegeneration in rats: similarity with paraquat neurotoxicity. Brain Res 2012, 1438:48-64.
30. Cristovao A.C., Choi D.H., Baltazar G., Beal M.F., Kim Y.S. The role of NADPH oxidase 1-derived reactive oxygen species in paraquat-mediated dopaminergic cell death. Antioxid Redox Signal 2009, 11(9):2105-2118.
31. Migheli R., Godani C., Sciola L., Delogu M.R., Serra P.A., Zangani D., et al. Enhancing effect of manganese on l-DOPA-induced apoptosis in PC12 cells: role of oxidative stress. J Neurochem 1999, 73(3):1155-1163.
32. Chan S.W., Dunlop R.A., Rowe A., Double K.L., Rodgers K.J. l-DOPA is incorporated into brain proteins of patients treated for Parkinson's disease, inducing toxicity in human neuroblastoma cells in vitro. Exp Neurol 2011, http://dx.doi.org/10.1016/j.expneurol.2011.09.029, in press. PubMed ID: 22001774.
33. Barone M.C., Sykiotis G.P., Bohmann D. Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson's disease. Dis Model Mech 2011, 4(5):701-707.
34. Bandyopadhyay J., Song H.O., Park B.J., Singaravelu G., Sun J.L., Ahnn J., et al. Functional assessment of Nramp-like metal transporters and manganese in Caenorhabditis elegans. Biochem Biophys Res Commun 2009, 390(1):136-141.
35. Hoeven R., McCallum K.C., Cruz M.R., Garsin D.A. Ce-Duox1/BLI-3 generated reactive oxygen species trigger protective SKN-1 activity via p38 MAPK signaling during infection in C. elegans. PLoS Pathog 2011, 7(12):e1002453.
36. Mosley R.L., Hutter-Saunders J.A., Stone D.K., Gendelman H.E. Inflammation and adaptive immunity in Parkinson's disease. Cold Spring Harb Perspect Med 2012, 2(1):a009381.